(COMTEX) B: Univec Receives FDA 510-k- Clearance for Its New Bifurcated
B: Univec Receives FDA 510-k- Clearance for Its New Bifurcated Safety Needle
Specifically Designed for U.S. and International Smallpox Vaccine Programs
FARMINGDALE, N.Y., Mar 25, 2002 (BUSINESS WIRE) -- Farmingdale-based Univec,
Inc., (OTCBB:UNVC - news) a leading manufacturer of patented auto-disable and
safety syringes, distributor of physician samples and medical waste management
technology, today announced FDA 510(k) clearance for its new Bifurcated Safety
Needle.
Univec's Bifurcated Safety Needle was specifically designed to meet the U.S.
Government requirements for safe administration of the smallpox vaccine.
Univec's patented Bifurcated Safety Needles are the only bifurcated needles
available that employ a sliding sheath mechanism that complies with the U.S.
Needle Stick Law and OSHA regulations to effectively reduce the risk of
accidental needle sticks.
According to Joel Schoenfeld, Univec's Chairman, and inventor of the Bifurcated
Safety Needle, "Syringe and needle device manufactures have an obligation to the
U.S. government and the people we serve, to offer safety devices that comply
with the U.S. Needle Stick Law and OSHA requirements to protect patients and
healthcare workers, and the New Univec Bifurcated Safety Needle does that."
This new device continues to add to the growth of products and services that
Univec has in its pipeline of new products for safer health products to patients
and caregivers worldwide.
About Univec
Founded in 1992, Univec is considered one of the leading innovators in the
design and production of auto-disable and safety syringes, and with it's
acquisition of Physician and Pharmaceutical Services, Inc. and Thermal Waste
Technologies Inc., provides safe delivery of physician samples and disposal of
infectious medical waste. The Company has production facilities in Portugal,
South Korea, China, Belgium and the U.S., and has licensed its technology to
Terumo of Belgium; a subsidiary of Terumo Japan, the leading producer of
syringes outside the U.S. Univec distributes its products in 80 countries.
Forward Looking Statements
This document contains forward-looking statements based on current expectations
that could be affected by the risks and uncertainties involved in Univec's
business. These risks and uncertainties include, but are not limited to, the
risks described from time to time in Univec's reports to the Securities and
Exchange Commission, which include Univec's Annual Report on Form 10-K.
Subsequent written or oral statements attributable to Univec or persons acting
on its behalf are expressly qualified in their entirety by the cautionary
statements in this document and those in Univec's reports filed with the SEC.
CONTACT: Allegent Growth Strategies International, Woodbury
G. Edward Kalbaugh, 516/364-7034
e-mail gekalbaugh@allegentgsi.com
URL: businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2002 Business Wire. All rights reserved.
-0-
KEYWORD: NEW YORK
INDUSTRY KEYWORD: BIOTECHNOLOGY
MEDICAL
MEDICAL
DEVICES
SOURCE:
Univec,
Inc.
*** end of story *** |
